Through a combined structural and functional analysis, our study reveals the molecular basis for the pathogenic effect of these mutations and identifies polymerization attenuation as a strategy of therapeutic intervention, with important implications in drug development against AML and other DNMT3A-associated diseases. Here, DNMT3A is linked to acute myeloid leukemia.